Second-line antiretroviral therapy in resource-limited settings: the experience of Médecins Sans Frontières.
OBJECTIVES: To describe the use of second-line protease-inhibitor regimens in Médecins Sans Frontières HIV programmes, and determine switch rates, clinical outcomes, and factors associated with survival.